Cargando…
Tumor suppressor FLCN inhibits tumorigenesis of a FLCN-null renal cancer cell line and regulates expression of key molecules in TGF-β signaling
BACKGROUND: Germline mutations in the FLCN gene are responsible for the development of fibrofolliculomas, lung cysts and renal neoplasia in Birt-Hogg-Dube' (BHD) syndrome. The encoded protein folliculin (FLCN) is conserved across species but contains no classic motifs or domains and its functio...
Autores principales: | Hong, Seung-Beom, Oh, HyoungBin, Valera, Vladimir A, Stull, Jaime, Ngo, Duy-Tan, Baba, Masaya, Merino, Maria J, Linehan, W Marston, Schmidt, Laura S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2907329/ https://www.ncbi.nlm.nih.gov/pubmed/20573232 http://dx.doi.org/10.1186/1476-4598-9-160 |
Ejemplares similares
-
Inactivation of the FLCN Tumor Suppressor Gene Induces TFE3 Transcriptional Activity by Increasing Its Nuclear Localization
por: Hong, Seung-Beom, et al.
Publicado: (2010) -
Blood and lymphatic systems are segregated by the FLCN tumor suppressor
por: Tai-Nagara, Ikue, et al.
Publicado: (2020) -
Role of FLCN Phosphorylation in Insulin‐Mediated mTORC1 Activation and Tumorigenesis
por: Wang, Guoyan, et al.
Publicado: (2023) -
The tumor suppressor FLCN mediates an alternate mTOR pathway to regulate browning of adipose tissue
por: Wada, Shogo, et al.
Publicado: (2016) -
Characterization of a splice-site mutation in the tumor suppressor gene FLCN associated with renal cancer
por: Bartram, Malte P., et al.
Publicado: (2017)